ATLAS Board

One of the major goals of the ATLAS project is to expand into an international clinical trial group based on the network with Asian countries established through the ATLAS project. There are large-scale international clinical trial groups in Europe and the United States, and each group has excellent systems in place to efficiently conduct international collaborative clinical trials. As the first step in establishing such a system as an international clinical trial group, we established the ATLAS Board on March 16, 2023, consisting of representatives from Asian countries.

The Board has the authority to discuss and approve the future direction, strategy, and activities of ATLAS. Board meetings are held four times a year, where participating members discuss a variety of topics from diverse perspectives and are responsible for developing ATLAS as a sustainable international clinical trial group.

The ATLAS Board consists of the following members. Members are chosen from institutions that participate in ATLAS clinical research and enrolling patients.